165 related articles for article (PubMed ID: 35947350)
1. Identification of Metastasis-Associated Genes in Cutaneous Squamous Cell Carcinoma Based on Bioinformatics Analysis and Experimental Validation.
Chen L; Liao X; Jiang X; Yan J; Liang J; Hongwei L
Adv Ther; 2022 Oct; 39(10):4594-4612. PubMed ID: 35947350
[TBL] [Abstract][Full Text] [Related]
2. Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma.
Chen H; Yang J; Wu W
BMC Cancer; 2021 Jul; 21(1):852. PubMed ID: 34301206
[TBL] [Abstract][Full Text] [Related]
3. Novel Signaling Pathway and NSC689534 as a Potential Drug Candidate for Cutaneous Squamous Cell Carcinoma.
Miao Y; Shen C; Zhang X; Li QQ; Pang AY; Zhao WM; Wu XY; Qian HY; Chen XD
Front Biosci (Landmark Ed); 2024 Jan; 29(1):19. PubMed ID: 38287820
[TBL] [Abstract][Full Text] [Related]
4. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
[TBL] [Abstract][Full Text] [Related]
5. Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.
He C; Ren L; Yuan M; Liu M; Liu K; Qian X; Lu J
BMC Womens Health; 2022 Sep; 22(1):365. PubMed ID: 36057587
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer.
Zhang Y; Li N; Yuan G; Yao H; Zhang D; Li N; Zhang G; Sun Y; Wang W; Zeng J; Xu N; Liu M; Wu L
BMC Med; 2022 Feb; 20(1):55. PubMed ID: 35130902
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
8. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry.
Azimi A; Lo K; Kim J; Fernandez-Penas P
J Dermatol Sci; 2020 Aug; 99(2):119-127. PubMed ID: 32651104
[TBL] [Abstract][Full Text] [Related]
9. Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells.
Rahmati Nezhad P; Riihilä P; Piipponen M; Kallajoki M; Meri S; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Nov; 30(11):1631-1641. PubMed ID: 33813765
[TBL] [Abstract][Full Text] [Related]
10. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
Zou S; Gao Y; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
[TBL] [Abstract][Full Text] [Related]
11. Integrated tissue proteome and metabolome reveal key elements and regulatory pathways in cutaneous squamous cell carcinoma.
Chen W; Rao J; Liu Z; You X; Yuan F; Le F; Tang M; Zhou M; Xie T
J Proteomics; 2021 Sep; 247():104320. PubMed ID: 34237460
[TBL] [Abstract][Full Text] [Related]
12. Identification of
Qin S; Yang Y; Zhang HB; Zheng XH; Li HR; Wen J
Transl Cancer Res; 2021 Jan; 10(1):469-478. PubMed ID: 35116276
[TBL] [Abstract][Full Text] [Related]
13. Multiple datasets to explore the tumor microenvironment of cutaneous squamous cell carcinoma.
Xing J; Chen M; Han Y
Math Biosci Eng; 2022 Apr; 19(6):5905-5924. PubMed ID: 35603384
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.
Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z
Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873
[TBL] [Abstract][Full Text] [Related]
15. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Chen IP; Bender M; Spassova I; Henning S; Kubat L; Fan K; Degenhardt S; Mhamdi-Ghodbani M; Sriram A; Volkmer B; Boukamp P; Becker JC; Greinert R
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3215-3231. PubMed ID: 32865618
[TBL] [Abstract][Full Text] [Related]
16. Genomic progression for local invasion of cutaneous squamous cell carcinoma from the superficial to the deep portion.
Hwang HW; Shin HT; An HY; Byun JW
Int J Cancer; 2024 Aug; 155(3):532-544. PubMed ID: 38739001
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: Analysis of recurrence-free survival.
Samsanavičius D; Kaikaris V; Norvydas SJ; Liubauskas R; Valiukevičienė S; Makštienė J; Maslauskas K; Rimdeika R
Medicina (Kaunas); 2016; 52(5):276-282. PubMed ID: 27746117
[TBL] [Abstract][Full Text] [Related]
18. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
[TBL] [Abstract][Full Text] [Related]
19. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes.
Li L; Li F; Xia Y; Yang X; Lv Q; Fang F; Wang Q; Bu W; Wang Y; Zhang K; Wu Y; Shen J; Jiang M
EBioMedicine; 2020 Jul; 57():102835. PubMed ID: 32574963
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
